V
Vericel Corporation
VCEL · NASDAQ · Healthcare · 2.3B
Price · close
$42.68
+1.35% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
130.7×
Price / net assetsP/B
6.1×
Enterprise value / EBITDAEV/EBITDA
71.2×
Free cash flow yieldFCF yield
1.1%
Return on equityROE
4.7%
Operating margin
4.0%
Net debt / EBITDAbalance-sheet strength
-0.1×
Interest coverage
7.1×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.